These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 11347106)
1. [LIPID study [Long-term Intervention with Pravastatin in Ischaemic Disease study]]. Homma Y Nihon Rinsho; 2001 Mar; 59 Suppl 3():416-21. PubMed ID: 11347106 [No Abstract] [Full Text] [Related]
2. In patients with heart disease, is the benefit of lipid-lowering therapy with statins similar in older patients to that in younger patients? Adelman A J Fam Pract; 2001 Nov; 50(11):924. PubMed ID: 11711002 [No Abstract] [Full Text] [Related]
3. [Clinical study of the month. The LIPID study: "long-term intervention with pravastatin in ischaemic disease"]. Scheen AJ Rev Med Liege; 1999 Jan; 54(1):2-3. PubMed ID: 10081301 [TBL] [Abstract][Full Text] [Related]
5. Lipid lowering in post-MI patients with normal cholesterol. Lawless C; Force R J Fam Pract; 1997 Jan; 44(1):30. PubMed ID: 9010366 [No Abstract] [Full Text] [Related]
6. Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study. Hague W; Forder P; Simes J; Hunt D; Tonkin A; Am Heart J; 2003 Apr; 145(4):643-51. PubMed ID: 12679760 [TBL] [Abstract][Full Text] [Related]
7. [One year after WOSCOP, what is the correct pharmacological treatment of primary hypercholesterolemia? Réflexions du Groupe de Pharmacologie Clinique de la Société Française de Cardiologie]. Therapie; 1996; 51(6):611-4. PubMed ID: 9163995 [No Abstract] [Full Text] [Related]
8. Long-term follow-up of the West of Scotland Coronary Prevention Study. Ford I; Murray H; Packard CJ; Shepherd J; Macfarlane PW; Cobbe SM; N Engl J Med; 2007 Oct; 357(15):1477-86. PubMed ID: 17928595 [TBL] [Abstract][Full Text] [Related]
9. Overlap analysis of the West of Scotland coronary prevention study (WOSCOPS). Lim PO; Yee KM Circulation; 1999 Aug; 100(6):686. PubMed ID: 10441109 [No Abstract] [Full Text] [Related]
11. Recent developments in coronary heart disease prevention: the Scandinavian and west of Scotland studies. Elam MB; Cushman W; Applegate WB; Heimberg M Tenn Med; 1997 May; 90(5):189-92. PubMed ID: 9130876 [No Abstract] [Full Text] [Related]
12. Long-term follow-up of the West of Scotland Coronary Prevention Study. DeFilippis AP; Bansal S; Blumenthal RS N Engl J Med; 2008 Jan; 358(2):194; author reply 194-5. PubMed ID: 18193527 [No Abstract] [Full Text] [Related]
13. Japan: are statins still good for everybody? Sirtori CR; Calabresi L Lancet; 2006 Sep; 368(9542):1135-6. PubMed ID: 17011926 [No Abstract] [Full Text] [Related]
14. The effects of pravastatin on hospital admission in hypercholesterolemic middle-aged men: West of Scotland Coronary Prevention Study. J Am Coll Cardiol; 1999 Mar; 33(4):909-15. PubMed ID: 10091815 [TBL] [Abstract][Full Text] [Related]
15. Prevention of coronary heart disease with pravastatin. Davis DR N Engl J Med; 1996 May; 334(20):1334; author reply 1335. PubMed ID: 8609958 [No Abstract] [Full Text] [Related]
17. Prevention of coronary heart disease with pravastatin. Samani NJ; de Bono DP N Engl J Med; 1996 May; 334(20):1333-4; author reply 1334-5. PubMed ID: 8609957 [No Abstract] [Full Text] [Related]
18. A need to redefine the consensus on the use of statins in coronary heart disease prevention. Fruchart JC Eur Heart J; 2000 Oct; 21(19):1572-3. PubMed ID: 10988008 [No Abstract] [Full Text] [Related]